T-cell prolymphocytic leukemia in an adolescent with ataxia-telangiectasia: novel approach with a JAK3 inhibitor (tofacitinib)

• Geling Li,
• Emily Waite,
• Julie Wolfson

Affiliations

Geling Li

Department of Pathology and Laboratory Medicine and

Emily Waite

Department of Pharmacy, Children's of Alabama, Birmingham, AL; and

Julie Wolfson

Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, AL; Julie Wolfson, 1600 7th Ave S, Lowder 500, Birmingham, AL 35233;